Locations:
Min Investment:
Max Investment:
Target Investment:
2024
2018 - 2024
2016 - 2018
2016 - 2016
2022
2022
2018
2018
2018
The WRF-HEOR Fellowship aims to connect qualified researchers to meaningful health economic challenges facing Washington State life science companies. Health economics and outcomes research (HEOR) is increasingly being used at earlier stages of product development for healthcare and life sciences to inform decision making. While this expertise is commonly available at larger companies it may be unaffordable to smaller companies that have arguably the greatest need for that kind of service. The WRF-HEOR Fellowship would aim to address this gap by providing high-quality health economic and outcomes research services to WRF mission-related companies coming from qualified institutions in Washington state while also providing a valuable training activity for graduate students at Washington state research institutions.
2020 - 2023
Designed and taught PHARM 540: Systematic Reviews and Meta-Analyses in the UW School of Pharmacy.
2018
This course is designed to give students an overview of the challenges that are necessary for any young business in healthcare or life sciences to consider. By the end of the course, students should expect to have an awareness of the system of regulation of health technologies, the process of development for health technologies, and the economics of healthcare. https://foster.uw.edu/centers/buerk-ctr-entrepreneurship/entrepreneurship-competitions/uw-health-innovation-challenge/
2023 - 2024
2023 - 2024
2023 - 2024
2023 - 2024
2017 - 2018
2017 - 2018
2013 - 2017
2013 - 2017
Health economics and outcomes research consultant for clients including: MedImmune/AstraZeneca, Genentech, and the National Pharmaceutical Council. Involved in generation of numerous drug's economic evidence for AMCP dossier.
2014 - 2015
2014 - 2015
Research assistant for the NIH funded Personalized Medicine Economics Research (PriMER) project. My responsibilities involved organization, execution and analysis of focus groups and interviews with patients, providers and payers on the value of companion diagnostics and personalized medicines to healthcare consumers.